Absolute Pro Vascular
Abbott Vascular, Inc. · Decision date Oct 22, 2025
What did the FDA decide?
FDA records P110028/S025 as a supplement to PMA P110028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 22, 2025.
FDA approval order statement
approval for a change to the sponge used during the catheter lubricious coating application process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 22, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110028/S025
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott Vascular, Inc.
- Product code
- NIO
- Decision code
- OK30
- Decision date
- Oct 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: STENT, ILIAC.
- Applicant
- Abbott Vascular, Inc.
- Product code
- NIO
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P110028/S024 · Related supplement
Absolute Pro Vascular Self-Expanding Stent System
P110028/S025 received
Application receipt date recorded by FDA.
P110028/S025 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P110028. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110028
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Vascular, Inc. | PMA supplement | Jul 22, 2025 | FDA |
Explore the linked device profile
Other records with product code NIO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook Ireland, Ltd. | PMA supplement | Nov 6, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
S.M.A.R.T. CONTROL Nitinol Stent SystemP020036/S061 | Cordis US Corporation | PMA supplement | Oct 15, 2026 | FDA |
| Biotronik AG | PMA supplement | Sep 11, 2026 | FDA | |
Epic Vascular Self-Expanding Stent SystemP110035/S079 | Boston Scientific Corp | PMA supplement | Aug 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3200 Lakeside Dr., Santa Clara, CA, 92054
Sources and methodology
- Original FDA record: P110028/S025
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



